Vivakor, Inc. (OTC:VIVK) has announced that it has entered into an exclusive license and purchase agreement with Regeneca International, Inc worth $5 million. The agreement grants exclusive licenses to Regeneca to distribute Vivakor’s nutraceutical formulation. Regeneca is committed to a $5 million purchase from Vivakor as part of the agreement, while Vivakor, Inc. will receive 15% ownership interest in Regeneca’s outstanding common stock.
MicroCap Insider is a web-based financial portal that publishes a free penny stock newsletter providing stock alerts on companies positioned to deliver high-yield gains to investors. Sign Up for our Free Stock Newsletter
A transdisciplinary research company, Vivakor is engaged in the development of products in the areas of molecular medicine, electro-optics, biological handling, and natural formulary compounds. Vivakor performs contract research and development in molecular biology and devices engineering. The company owns 84% of HealthAmerica, Inc. as of October 20, 2008.
Investors interested in receiving small cap stock alerts through the penny stock newsletter published by MicroCap Insider can sign up for free by visiting our website
About Us
MicroCap Insider is a leading penny stock web site with extensive experience in the OTC market, providing top stock picks, investing tips and exclusive research on small cap stocks on the verge of producing large financial gains.
Please click here to read the full disclaimer
